Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.


CSE:SONA - Post by User

Post by Pandoraon May 21, 2024 7:34pm
317 Views
Post# 36051004

New Press Release

New Press Release
SONA moving in to the big leagues i.e. they have hired a Chief Medical Officer to oversee and guide the Company as they carry the Company into the throes of FDA and HC approval adventures.

Sona Appoints Chief Medical Officer and Files Provisional Conjugation Patent

Newsfile 10 hours ago

The only problem I have with this is the amount of time involved in getting said approvals. I have a couple others in the pharma sector and it seems ten years is not an unrealistic time frame to look at in making their way through about 3 phases of Trials.

I am too old for that so may not be seeing their end success. :-))

<< Previous
Bullboard Posts
Next >>